Common bacteria ‘fuels millions of cases of stomach cancer across the globe'
Scientists from the International Agency for Research on Cancer (IARC) – part of the World Health Organisation – project that, if nothing is done, around 15.6 million people across the globe born between 2008 and 2017 will be diagnosed with stomach (gastric) cancer in their lifetime.
Of these cases, some 11.9 million (76%) will be due to infection with Helicobacter pylori (H. pylori).
While the vast majority of new cases will be in Asia (particularly India and China), some two million could occur in the Americas, 1.7 million in Africa and 1.2 million in Europe.
H. pylori is a bacteria that infects the lining of the stomach and is thought to be spread from person to person and via contaminated food and water.
Research is still ongoing into how the infection is spread and how it may cause stomach cancer and another type, non-Hodgkin lymphoma.
For many people, H. pylori does not cause issues and will not need the standard treatment of antibiotics, but it can be the cause of ongoing indigestion, bloating or nausea.
H. pylori is detected with a blood test, breath test or via a stool sample.
The authors of the latest study are now calling for greater investment in the prevention of stomach cancer, particularly through population-wide 'screen and treat' programmes for H. pylori.
However, Cancer Research UK said stomach cancer rates in the UK have actually been falling – over the last decade, they have dropped 26% and are projected to fall further by 2040.
Health information manager at Cancer Research UK, Dr Rachel Orritt, said: 'H. pylori infection increases the risk of stomach cancer, but it's not a common infection in the UK.
'It's also important to note that stomach cancer cases have been decreasing in the UK for decades, and they're expected to continue to fall.
'Although this is an important issue worldwide, in the UK other preventable factors cause more cancer cases.
'Ways to reduce your cancer risk include stopping smoking, keeping a healthy weight, cutting down on alcohol and eating a healthy, balanced diet.'
For the Nature Medicine study, scientists examined the incidence of stomach cancer from 185 countries in 2022 and combined it with projections of future deaths.
They looked at the potential impact of screen-and-treat strategies for H. pylori and found the number of stomach cancers could be cut by up to 75% overall.
Asia accounts for two thirds of projected future cases, with 10.6 million cases (68% of the total), followed by the Americas (2m or 13%), Africa (1.7 million or 11%), Europe (1.2m or 8%), and Oceania (0.07m or 0.4%).
Dr Jin Young Park, leader of the gastric cancer prevention team at IARC and co-author of the study, said: 'It is essential that health authorities make gastric cancer prevention a priority and accelerate efforts to control it by planning pilot and feasibility projects, including H. pylori screen-and-treat programmes.'
The main symptoms of stomach cancer include heartburn or acid reflux, having problems swallowing, feeling or being sick, indigestion and burping and feeling full very quickly when eating.
These symptoms are common and usually caused by other conditions.
Other symptoms include loss of appetite or losing weight without trying, stomach pain, a lump feeling at the top of the stomach and feeling very tired.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
11 hours ago
- BBC News
Malaria: First treatment approved for babies
A treatment to help babies and very young children infected by malaria has been approved. Malaria is a disease spread by a particular type of mosquito and can be life-threatening if it isn't treated quickly. It is particularly harmful for young children and babies and until now, there hasn't been a treatment specifically made to help them. It's expected to be rolled out in African countries - where the deadly disease is most commonly found - within the next few weeks. What is Malaria? Malaria is a deadly disease caused by a particular kind of infected mosquito called the Anopheles, which is typically most active at night. It's a huge problem in countries across Asia, Africa and South to the World Health Organisation's (WHO) most recent figures, there were around 263 million cases of malaria in the world in 2023. Most cases occur in Africa (94% in 2023) and the disease is particularly harmful to young is not found in the UK and you can't catch the disease from another person. A vaccine to help prevent cases of malaria was recommended by the WHO in October 2021 and has helped to reduce the amount of deaths due to the disease. Malaria treatments for children do exist but not specifically for very young children and is the first time a drug to treat Malaria in young children has ever been approved. Previously they have been treated with medicine designed for older children which is a risk as babies' livers are still developing and their bodies process it been developed by a company called Novartis and it is planning to introduce it in a way that means they don't earn a profit - it makes the healthcare more accessible. Chief executive Vas Narasimhan said it's an important moment: "The smallest and most vulnerable can finally receive the care they deserve."
Daily Mirror
12 hours ago
- Daily Mirror
'Botched smear results mean I'll never be a mum - my insides are a mess'
Sarah Waters, 33, was diagnosed with cervical cancer in 2022 after a routine smear test and has since had a full hysterectomy - saying the experience left her "broken" A woman who was diagnosed with cervical cancer said she's been left "devastated" by the NHS's decision to increase the gap between cervical smear tests. From July onwards, women aged 25 to 49 who have tested negative for high-risk HPV will see their Pap smear routine change from every three years to every five years. This shift is based on new clinical evidence that supports HPV testing as a reliable method for identifying those at risk of cervical cancer, thus allowing for more extended intervals between check-ups without risking safety. Nevertheless, the adjustment has sparked fear in some women, who believe that less frequent testing could cause cases to be missed. For Sarah Waters, who received her cervical cancer diagnosis after a regular screening, this update is harrowing. She insists that frequent tests are "absolutely crucial". Her scheduled smear test in 2020 was delayed due to the pandemic, but she finally got an appointment and underwent screening on April 1, 2022. The 33 year old presumed all was well when she didn't receive immediate feedback, and so she flew off to Spain at the end of May. Yet, when she returned to her home in Prescot on June 2, she discovered "urgent letters" instructing her to visit the hospital following concerning screening results, reports the Liverpool Echo. On June 22, the singer was dealt a crushing blow with a diagnosis of a rare form of cervical cancer known as poorly-differentiated squamous cell carcinoma. Described as "aggressive, fast growing and invasive" the news came as "a complete shock" to Sarah, who subsequently underwent a full hysterectomy. This procedure has sadly eliminated her chances of having biological children, leaving her feeling "broken". She revealed that she is "suffering with menopause really badly", adding: "I can't believe it when I'm there having a hot flush, or brain fog, it's a nightmare." Post-surgery, Sarah was confronted with further distressing news - the cancer had metastasised to her lymph nodes, necessitating eight weeks of chemotherapy and radiotherapy. Sarah alleges that the radiotherapy treatment "absolutely messed up [her] insides" - she now grapples with additional health issues, including bowel problems. What's more, her cancer diagnosis came after irregular findings on her 2018 smear were ignored. Sarah disclosed: "I found out in 2023, exactly a year after I was diagnosed, a smear test I had in 2018 showed abnormalities and was recorded as negative - a false negative result. If they had recorded it accurately, I would have gone back before then and it probably would have prevented everything that's happened." When questioned about recent changes in NHS policy, Sarah labelled them as "ridiculous", asserting that regular smear tests are "absolutely crucial". Cancer Research UK maintains that cervical screening is typically 'very effective', but acknowledges the risk of cell changes being overlooked, leading to a false negative result. Sarah shared her distressing story, grappling with the long-term impacts of her health: "I'm trying to come to terms with the fact that my life is ruined. I can't have a child, I'm in the menopause, I couldn't work for a long time and I've got all these problems with my bowels and stuff." Addressing concerns about the screening process, she stated: "This change could cost lives. Some people have passed away because it's been too late. It's a screening program. There's always a chance it could be a false negative which means surely we should have more regular screening programs to make sure we're checking?". She further criticised the extended intervals between screenings: "The fact that they're making it longer is ridiculous. In my experience, it was four years from my previous smear test. I had cancer, and there was no margin, it wasn't even just a bit. I had cancer, and I had to go straight for a hysterectomy. That was my only option." Highlighting the need for a comprehensive strategy, Sarah argued: "I do think the minimum age should be lowered too, some can get cancer at 24, you just don't know what is happening. As well though, the HPV virus, many parents don't let their kids get the vaccine and HPV can develop in cervical cancer." Emphasising the invisibility of internal health issues, she said: "Everything can look normal but you don't know what's happening inside." In an urgent plea, Sarah encouraged women to stay on top of their health checks: "Make sure you go regularly, it shouldn't get to that. Please just don't put it off, it can save your life." For those seeking more details regarding cervical screening, the NHS website offers comprehensive information.
The Sun
14 hours ago
- The Sun
Teenage girl dies from ‘brain-swelling' Nipah virus considered the ‘next pandemic' – as officials detect a second case
A TEENAGE girl has died from a brain-swelling bat virus which experts fear could be the 'next pandemic'. The 18-year-old tested positive for Nipah virus, an extremely lethal isease and kills more two thirds of those infected. 3 3 It belongs to the same family as measles and, like measles, spreads easily between people and is highly contagious. Health officials are now racing to trace hundreds of potential contacts, some of which are already in intensive care. The young girl died in hospital in Kerala, South India on July 1, according an editorial in The Hindu. Since then, a 38-year-old woman from Palakkad village, about 80 km (2.5 hours by car) from Malappuram, where the teenager fell ill, has also tested positive. A total of 425 people across three districts have been identified as contacts of the two women, who could have come in contact at a social event. Among them, 12 are receiving treatment, including five in intensive care, while results for many are still awaited. The World Health Organization (WHO) lists Nipah as a virus with pandemic potential. list of 24 diseases considered the greatest future threats to public health. Niaph, which inspired the blockbuster film Contagion starring Gwyneth Paltrow, is a zoonotic virus. This means it can be transmitted from animals to humans. Much like the virus in the film, which centered around a global pandemic, it attacks the brain, can spread from human-to-human and has a fatality rate as high as 75 per cent. Of those who survive it, around 20 per cent are left with long-term neurological conditions, including personality changes or seizure disorders. For comparison, estimates from John Hopkins University dashboard suggest the fatality rate of Covid is just over one per cent. There's currently no approved vaccine to prevent Nipah virus infections and no treatment to cure it. However, Oxford scientists have developed the first Nipah vaccine to enter human trials, with early tests now underway. Kerala has experienced multiple outbreaks of the virus since it was first detected there in 2018, resulting in dozens of deaths across the state. Other outbreaks have been reported in Bangladesh, Malaysia, the Philippines, and Singapore. 3 An investigation published by Reuters last year, found that Kerala - which is a tropical state and is witnessing rapid urbanisation and tree loss - had "ideal conditions for a virus like Nipah to emerge". India's worst outbreak of the virus occurred in 2001 in the northwestern state of West Bengal when 45 out of 66 people confirmed to have had Nipah died. Is Nipah virus threat to the UK? By Paul Hunter, professor of medicine at the University of East Anglia Nipah virus is a nasty disease. Although everything is possible in the world of infectious diseases. The threat of a global Nipah virus pandemic is not high on the list of the things that keep we awake at night. Firstly, the primary host species are Pteropodidae bats, fruit bats or a flying fox. Humans usually catch the infection from an infected animal, either the fruit bats themselves or from intermediate animals such as pigs, Contaminated food can also be a cause. The pigs catch the infection from the fruit bats. Pteropodidae bats are not found in Europe -see figure below. Secondly, person to person transmission does occur but it is not very efficient. The R-value is below 1.0, around 0.33, so you would not get sustained person-to-person transmission unless there was some pretty impressive evolution, not impossible but very unlikely. I guess there could be a risk of introduction into the UK from contaminated food, probably meat illegally brought into the country. However, any subsequent illnesses would not spread far. Of course with climate change the distribution of species may change over the next century and who knows what the risk may be in 50 or 100 years from now. Experts say that animals are living in closer proximity to humans due to habitat loss, which helps the virus jump from animals to humans and poses a risk for outbreaks. Nipah is typically transmitted to humans from animals such as bats and pigs, through direct contact with bodily fluids like blood or saliva. Humans can also pick the disease up by eating foods contaminated with urine or saliva from infected animals. They can also pick it up through close contact with people who already have it - but these forms of transmission are much rarer. People infected with the Nipah virus my not display any symptoms at all. But many go on to develop acute respiratory infections, seizures and fatal brain swelling, called encephalitis. Encephalitis and seizures only occur in severe cases and can progress to coma within 24 to 48 hours. It typically takes between four days and two weeks for people to develop symptoms after being infected. However, in some cases it has taken up to 45, WHO noted. Extremely likely to see outbreaks Scientists previously told The Sun that Nipah could 'absolutely be the cause of a new pandemic'. Dr Rebecca Dutch, chair of the University of Kentucky, and a world a leader in the study of viruses, said that although there are no current Nipah outbreaks in the world, they occur periodically and it is 'extremely likely' we will see more. She told us: 'Nipah is one of the viruses that could absolutely be the cause of a new pandemic. Several things about Nipah are very concerning. 'Many other viruses in that family (like measles) transmit well between people, so there is concern that a Nipah variant with increased transmission could arise. 'The mortality rate for this virus is between 45 per cent and 75 per cent depending on the outbreak – so this is much higher than Covid-19. "Nipah has been shown to be transmitted through food, as well as via contact with human or animal excretions. 'The incubation period for Nipah can be quite long, and it can be unclear if transmission can occur during this time.' Dr Jonathan Epstein, vice president for science and outreach at the EcoHealth Alliance, explained how they are tracking the Nipah virus and are worried about its potential. He told The Sun: 'We know very little about the genetic variety of Nipah-related viruses in bats, and what we don't want to happen is for a strain to emerge that is more transmissible among people." THE 24 'PRIORITY PATHOGENS' THE UK Health Security Agency has issued a list of the 24 viruses and bacteria that its experts believe pose the biggest threat to people in the UK. Each one is a scientific family, meaning it is an umbrella term that includes and number of more specific - and usually better known - infections. VIRUSES Adenoviruses (mostly cause the common cold) Arenaviruses (e.g. Lassa fever) Calciviruses (e.g. norovirus) Coronaviruses (e.g. Covid-19) Filoviruses (e.g. Ebola, Marburg, Sudan virus) Flaviviruses (e.g. dengue, zika, hepatitis C) Hantaviruses (can cause hantavirus pulmonary syndrome) Nairoviruses (e.g. Crimean-Congo Haemorrhagic fever) Orthomyxoviruses (e.g. flu) Paramyxoviruses (e.g. Nipah virus) Peribunyaviruses (e.g. oropouche fever) Phenuviruses (e.g. Rift Valley fever) Picornaviruses (e.g. polio) Pneumoviruses (e.g. human metapneumovirus/hMPV) Poxviruses (e.g. mpox) Togaviruses (e.g. Chikungunya) BACTERIA Bacillaceae (e.g. anthrax) Coxiellaceae (e.g. Q fever) Enterobacteria (e.g. plague) Francisellacae (e.g. tularaemia) Moraxellaceae (can cause pneumonia and UTIs) Neisseriaceae (e.g. gonorrhoea) Staphylococcaceae (cause cellulitis, pneumonia) Streptococcaceae (cause meningitis, scarlet fever, septicaemia)
